University of Manchester

Manchester, United Kingdom
Purpose
to evaluate the enzymatic options for lowering the cost of an HIV anti-retroviral active pharmaceutical ingredient (API) synthesis, which will facilitate the future generic market entry of this API for low and middle income countries
Grantee
Division
Global Health
Date
APRIL 2025
Region served
GLOBAL
Committed amount
$252,820
Grant topic
HIV
Duration (months)
13
Grantee location
Manchester, United Kingdom
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.